Show source-provided references
1. Tkaczyk, M., Kuśka-Kielbratowska, A., Fiegler-Rudol, J., Niemczyk, W., Mertas, A., Skaba, D., and Wiench, R. (2025). The Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis—A Retrospective Study. Antibiotics, 14.
10.3390/antibiotics14090876 ↗4. Vila, T., Sultan, A.S., Montelongo-Jauregui, D., and Jabra-Rizk, M.A. (2020). Oral candidiasis: A disease of opportunity. J. Fungi, 6.
10.3390/jof6010015 ↗5. A review on oral Candida as commensal and opportunistic pathogen
6. Candida colonization in HIV-infected patients in Londrina-PR, Brazil: Antifungal susceptibility and virulence factors
10.3855/jidc.6970 ↗8. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a residual concentration
10.1053/jhin.2000.0851 ↗12. Angjelova, A., Jovanova, E., Polizzi, A., Leonardi, R., and Isola, G. (2025). Effects of antiseptic formulations on oral microbiota and related systemic diseases: A scoping review. Antibiotics, 14.
10.3390/antibiotics14080815 ↗16. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis
10.1093/jac/48.3.450 ↗17. A review of human studies assessing cannabidiol’s (CBD) therapeutic actions and potential
10.1002/jcph.1387 ↗18. David, C., Elizalde-Hernández, A., Barboza, A.S., Cardoso, G.C., Santos, M.B.F., and Moraes, R.R. (2022). Cannabidiol in dentistry: A scoping review. Dent. J., 10.
10.3390/dj10100193 ↗19. Comparative evaluation of a novel herbal anesthetic gel and 2% lignocaine gel as an intraoral topical anesthetic agent in children: Bilateral split-mouth, single-blind, crossover in vivo study
10.4103/JISPPD.JISPPD_226_20 ↗20. Evaluation of antibacterial potential of medicinal plant Spilanthes acmella Murr. and its in vitro raised callus against resistant organisms especially those harbouring bla genes
23. Comparison of the efficacy of simple and combined oral rinses with chlorhexidine digluconate against selected bacterial and yeast species: An in vitro study
10.17219/dmp/187834 ↗24. Kępa, M., Miklasińska-Majdanik, M., Haczyk, A., Matuła, A., and Wojtyczka, R.D. (2025). Caffeic acid and erythromycin: Antibacterial and synergistic effects on staphylococci. Pharmaceuticals, 18.
10.3390/ph18070964 ↗27. Feldman, M., Sionov, R.V., Mechoulam, R., and Steinberg, D. (2021). Anti-biofilm activity of cannabidiol against Candida albicans. Microorganisms, 9.
10.3390/microorganisms9020441 ↗28. Ferraz, M.P. (2025). The potential of cannabidiol in the management of oral infections. Appl. Sci., 15.
10.3390/app15105736 ↗29. Iacovelli, F., Romeo, A., Lattanzio, P., Ammendola, S., Battistoni, A., La Frazia, S., Vindigni, G., Unida, V., Biocca, S., and Gaziano, R. (2023). Deciphering the broad antimicrobial activity of Melaleuca alternifolia tea tree oil by combining experimental and computational investigations. Int. J. Mol. Sci., 24.
10.3390/ijms241512432 ↗30. Effect of cannabidiol (CBD), a cannabis plant derivative, against Candida albicans growth and biofilm formation
10.1139/cjm-2024-0034 ↗31. Antimicrobial effect of Spilanthes acmella on Streptococcus mutans, Staphylococcus aureus, Enterococcus faecalis and Candida albicans in oral cavity
10.2298/SGS2501003T ↗32. Feldman, M., Gati, I., Sionov, R.V., Sahar-Helft, S., Friedman, M., and Steinberg, D. (2022). Potential combinatory effect of cannabidiol and triclosan incorporated into sustained release delivery system against oral candidiasis. Pharmaceutics, 14.
10.3390/pharmaceutics14081624 ↗33. Kiełbratowski, M., Kuśka-Kiełbratowska, A., Mertas, A., Bobela, E., Wiench, R., Kępa, M., Trzcionka, A., Korkosz, R., and Tanasiewicz, M. (2025). Evaluation of the effectiveness of a mouthwash containing spilanthol and cannabidiol on improving oral health in patients with gingivitis—Clinical trial. J. Clin. Med., 14.
10.3390/jcm14051641 ↗34. Antifungal activity of tea tree oil, chlorhexidine, and nystatin against Candida albicans: A comparative study
10.1590/pboci.2026.042 ↗35. Anti-fungal activity of four herbal mouthwashes versus chlorhexidine against Candida albicans and C. glabrata: A preliminary study
10.5812/chbs-142439 ↗36. Kuśka-Kiełbratowska, A., Wiench, R., Mertas, A., Bobela, E., Kiełbratowski, M., Lukomska-Szymanska, M., Tanasiewicz, M., and Skaba, D. (2022). Evaluation of the sensitivity of selected Candida strains to ozonated water—An in vitro study. Medicina, 58.
10.3390/medicina58121731 ↗37. Assessment of sensitivity of selected Candida strains on antimicrobial photodynamic therapy using diode laser 635 nm and toluidine blue—In vitro research
10.1016/j.pdpdt.2019.06.007 ↗